type 2 diabetes Flashcards
Metformin drug class
Biguanides
metformin target
AMP-kinase
metformin moa
increase the sensitivity of peripheral tissues to insulin and inhibits gluconeogenesis in the liver
metformin effect on senses
metallic taste
critical side effect of metformin
lactic acidosis
what condition and metformin are you worried about lactic acidosis
renal impairment
metformin dosent cause …
hypoglycaemia (requires endogenous insulin to work)
name a drug that causes taste distubance
amitriptyline = metallic taste
what enzyme does metformin inhibit
glycogen phosphorylase
gliclazide drug class
Sulfonylureas
gliclazide target
block ATP-sensitive K+ channels on β islet cell plasma membranes
what dont people like about gliclazide
weight gain
gliclazide moa
Reduced K+ efflux leading to β cell depolarisation, Ca2+ entry and insulin secretion
gliclazide side effects
Hypoglycaemia
Hyponatraemia
Hepatotoxicity
Hypersensitivity
when to with hold all diabetic drugs
ketoacidosis
name two Sulfonylureas
Glimepiride
gliclazide
glimepiride drug class
Sulfonylureas
glimepiride duration
long duration of action
overall action of glimepiride
stimulating the release of insulin from functioning pancreatic beta cells, and increasing sensitivity of peripheral tissues to insulin
what does glimepiride bind to
ATP-sensitive potassium channel receptors on the pancreatic cell surface
glimepiride moa
potassium blocking = depolarization of the membrane = calcium ion influx through voltage-sensitive channels = secretion of insulin
repaglinide drug class
Meglitinides
repaglinide target
sulphonylurea type-1 receptor
repaglinide moa
Antagonism of this receptor prevents potassium ions from exiting the cell when intracellular ATP levels are low. potassium ions (K+) accumulate inside beta cells = depolarisation = insulin release
why are there no cardiac side effects with repaglinide
acts as an agonist at Sur-1 receptors. Thus no cardiac side effects as myocytes have Sur-2a subtype of sulphonylurea receptor
other good thing about repaglinide
prevention of beta cell apoptosis under heavy glucose load and prevention of fat accumulation in arteries
what is the sulphonylurea type-1 receptor part of
ATP-modulated potassium channel
where is sulphonylurea type-1 receptor found
beta cells of the pancreas
Glucagon-like peptide-1 analogues
Exenatide
Liraglutide